Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI

NCT03809273 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

681

Enrollment

OTHER

Sponsor class

Conditions

Percutaneous Coronary Intervention

Interventions

DRUG: Yangxinshi
DRUG: Trimetazidine
DRUG: Yangxinshi mimic
DRUG: Trimetazidine mimic

Sponsor

Shenyang Northern Hospital